Prevention of beta-cell destruction in autoimmune diabetes: current approaches and future prospects.

ABSTRACT

Type 1 diabetes (T1D) is an autoimmune disease resulting from the destruction of pancreatic beta-cells. The main aim of treatment should be to prevent beta-cell destruction and preserve existing beta-cells in individuals with progressive autoimmunity. This can be achieved in several ways and in this chapter the authors have reviewed recent approaches that are currently being tested in animal models and human T1D patients under the following categories i) antigen based therapy, ii) antibody-based therapy iii) other forms of therapy and iv) failed therapies.